DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,403,355 | -43.8% | 116,498 | -19.6% | 0.00% | 0.0% |
| Q2 2023 | $4,275,320 | +41.9% | 144,877 | +10.8% | 0.00% | 0.0% |
| Q1 2023 | $3,011,996 | -2.2% | 130,729 | +18.1% | 0.00% | 0.0% |
| Q4 2022 | $3,079,402 | -0.5% | 110,730 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $3,095,000 | -4.7% | 100,850 | -8.6% | 0.00% | 0.0% |
| Q2 2022 | $3,247,000 | -10.6% | 110,297 | -2.3% | 0.00% | 0.0% |
| Q1 2022 | $3,632,000 | -31.2% | 112,914 | -4.6% | 0.00% | 0.0% |
| Q4 2021 | $5,277,000 | -9.8% | 118,332 | +2.0% | 0.00% | -33.3% |
| Q3 2021 | $5,853,000 | -36.2% | 116,016 | -0.9% | 0.00% | -25.0% |
| Q2 2021 | $9,180,000 | +173.5% | 117,038 | +99.1% | 0.00% | +100.0% |
| Q1 2021 | $3,357,000 | -22.8% | 58,789 | +13.3% | 0.00% | -33.3% |
| Q4 2020 | $4,346,000 | +197.3% | 51,887 | +27.2% | 0.00% | +200.0% |
| Q3 2020 | $1,462,000 | +45.3% | 40,777 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $1,006,000 | -18.9% | 41,622 | -41.2% | 0.00% | 0.0% |
| Q1 2020 | $1,240,000 | -15.4% | 70,799 | -15.9% | 0.00% | 0.0% |
| Q4 2019 | $1,465,000 | -8.0% | 84,206 | -19.0% | 0.00% | 0.0% |
| Q3 2019 | $1,592,000 | +57.3% | 103,990 | +112.8% | 0.00% | 0.0% |
| Q2 2019 | $1,012,000 | +66.4% | 48,868 | +85.7% | 0.00% | – |
| Q1 2019 | $608,000 | +8.4% | 26,319 | -3.1% | 0.00% | – |
| Q4 2018 | $561,000 | -86.8% | 27,168 | -86.1% | 0.00% | -100.0% |
| Q3 2018 | $4,234,000 | +354.8% | 194,829 | +218.5% | 0.00% | – |
| Q2 2018 | $931,000 | +123.3% | 61,174 | +188.1% | 0.00% | – |
| Q1 2018 | $417,000 | – | 21,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 5,960,732 | $122,969,901 | 14.32% |
| ARCH Venture Management, LLC | 693,749 | $14,312,042 | 9.30% |
| Flagship Pioneering Inc. | 2,619,968 | $54,049,940 | 3.92% |
| Casdin Capital, LLC | 1,300,000 | $26,819,000 | 2.97% |
| Yiheng Capital Management, L.P. | 1,150,684 | $23,738,611 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 154,000 | $3,172,400 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 254,941 | $5,259,433 | 1.02% |
| Temasek Holdings (Private) Ltd | 6,895,992 | $142,264,315 | 0.85% |
| Clarius Group, LLC | 378,262 | $7,803,545 | 0.74% |
| Artal Group S.A. | 802,899 | $16,564 | 0.71% |